Summary

Countries covered: Global

The Alzheimer Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the Alzheimer's and dementia market, as well as sales of leading drugs and therapies are provided.

Please note, this file is delivered as a Word file.



Additional Information

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

I. OVERVIEW
General overview of the condition
Risk factors
Symptoms

II. INCIDENCE AND PREVALENCE
Incidence Table (US, UK, Eastern Europe, Northern Europe, Southern Europe, Western Europe)
Prevalence Table (US, Canada, UK, France, Italy, Spain, Japan, China, India, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Worldwide)

III. DIAGNOSIS
Tools and tests used to diagnose Alzheimer disease

IV. TREAMENT
Treating cognitive symptoms
Treating behavioral and psychiatric symptoms

V. DOSING
Dosing for FDA approved treatments

VI. TREATMENT COSTS
Costs for commonly prescribed non-generic drugs

VII. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VIII. COMMENTS
IX. REFERENCES/RESOURCES